相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
Michael C. Milone et al.
MOLECULAR THERAPY (2009)
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
Carmine Carpenito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells
Keli L. Hippen et al.
BLOOD (2008)
CD28 costimulation is essential for human T regulatory expansion and function
Tatiana N. Golovina et al.
JOURNAL OF IMMUNOLOGY (2008)
Sleeping beauty transposon-mediated engineering of human primary T cells for therapy of CD19(+) lymphoid malignancies
Xin Huang et al.
MOLECULAR THERAPY (2008)
4-1BB regulates NKG2D costimulation in human cord blood CD8+ T cells
Young-June Kim et al.
BLOOD (2008)
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Steven A. Rosenberg et al.
NATURE REVIEWS CANCER (2008)
4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy
Hua Zhang et al.
JOURNAL OF IMMUNOLOGY (2007)
Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts
Renier J. Brentjens et al.
CLINICAL CANCER RESEARCH (2007)
Enhancement of the anti-leukemic activity of cytokine induced killer cells with an anti-CD19 chimeric receptor delivering a 4-1BB-ζ activating signal
Virna Marin et al.
EXPERIMENTAL HEMATOLOGY (2007)
Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains
Jinjuan Wang et al.
HUMAN GENE THERAPY (2007)
CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells
Claudia M. Kowolik et al.
CANCER RESEARCH (2006)
Similar potential to become activated and proliferate but differential kinetics and profiles of cytokine production of umbilical cord blood T cells and adult blood naive and memory T cells
F. M. Kloosterboer et al.
HUMAN IMMUNOLOGY (2006)
Addition of the CD28 signaling domain to chimeric T-cell receptors enhances chimeric T-cell resistance to T regulatory cells
A. Loskog et al.
LEUKEMIA (2006)
CD28 co-stimulation via tumour-specific chimaeric receptors induces an incomplete activation response in Epstein-Barr virus-specific effector memory T cells
B. Altvater et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posarcansplantation adoptive immunotherapy
LM Serrano et al.
BLOOD (2006)
A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells
MA Pulè et al.
MOLECULAR THERAPY (2005)
Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation
D Friedmann-Morvinski et al.
BLOOD (2005)
Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters
M Amendola et al.
NATURE BIOTECHNOLOGY (2005)
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia
C Imai et al.
LEUKEMIA (2004)
Genetic modification of T lymphocytes for adoptive immunotherapy
C Rossig et al.
MOLECULAR THERAPY (2004)
Activation of resting human primary T cells with chimeric receptors: Costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain
HM Finney et al.
JOURNAL OF IMMUNOLOGY (2004)
Central memory and effector memory T cell subsets: Function, generation, and maintenance
F Sallusto et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Identification of a murine CD28 dileucine motif that suppresses single-chain chimeric T-cell receptor expression and function
P Nguyen et al.
BLOOD (2003)
Reduced expression of NFAT-associated genes in UCB versus adult CD4+ T lymphocytes during primary stimulation
BA Kaminski et al.
BLOOD (2003)
Umbilical-cord blood transplantation for the treatment of cancer
JN Barker et al.
NATURE REVIEWS CANCER (2003)
Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15
RJ Brentjens et al.
NATURE MEDICINE (2003)
T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect
LJN Cooper et al.
BLOOD (2003)
Targeting tumours with genetically enhanced T lymphocytes
M Sadelain et al.
NATURE REVIEWS CANCER (2003)
Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulation
NM Haynes et al.
JOURNAL OF IMMUNOLOGY (2002)
Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors
NM Haynes et al.
BLOOD (2002)
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCR zeta/CD28 receptor
J Maher et al.
NATURE BIOTECHNOLOGY (2002)
Functional balance between T cell chimeric receptor density and tumor associated antigen density: CTL mediated cytolysis and lymphokine production
MEM Weijtens et al.
GENE THERAPY (2000)
分享论文
